Yun Zhou

4PUBLICATIONS
0CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical infection agents (incl. prions)BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 30, 2025
Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials.

Jiaman Liu, Fenghua Yang, Boya Gao

|Sep 23, 2025
Resmetirom: The First FDA-Approved Drug for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with a Perspective on Precision Medicine.

Fengshuo Zhang, Yicong Meng, Bohan Zhao

|May 09, 2024
Bile acid-microbiota crosstalk in hepatitis B virus infection.

Jiaxin Wang, Huimin Xu, Zixin Liu

|Sep 22, 2023
The TICE Pathway: Mechanisms and Potential Clinical Applications.

Huimin Xu, Yiyang Xin, Jiaxin Wang

Pageof 1

Frequent Collaborators